María José Guillén

Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A

Kris M. White, Romel Rosales, Soner Yildiz et al. · Science · 2021 · 356 citations · Full text

Medicine, Viral Pathogenesis, Immunology +14

Tailor-made PEG coated iron oxide nanoparticles as contrast agents for long lasting magnetic resonance molecular imaging of solid cancers

Ana Lázaro-Carrillo, Marco Filice, María José Guillén et al. · Materials Science and Engineering C · 2019 · 68 citations

Nanoparticles, Nanomedicine, Engineering +13

Carbon Monoxide-Releasing Molecules: A Pharmacological Expedient to Counteract Inflammation

María José Alcaraz García, María José Guillén, Javier Megías et al. · Current Pharmaceutical Design · 2008 · 49 citations

Lung Inflammation, Immunology, Carbon Monoxide-releasing Molecules +19

A new potential nano-oncological therapy based on polyamino acid nanocapsules

Teresa Gonzalo, Giovanna Lollo, Marcos García-Fuentes et al. · Journal of Controlled Release · 2013 · 36 citations · Full text

Nanoparticles, Nanomedicine, Engineering +6

Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative

Giovanna Lollo, Pablo Hervella, Pilar Calvo et al. · International Journal of Pharmaceutics · 2015 · 29 citations · Full text

Nanoparticles, Nanomedicine, Engineering +9